CRTC3 and hepatocellular carcinoma: Evaluation of sensitizing effects of CRTC3 depletion to sorafenib treatment revealed significantly enhanced anti-tumor effects in CRTC3-KO HCC cells (Fig. 5a, b), which were separately rescued by Ferrostatin-1 and PRGL493 treatments (Fig. 5c).